GO:0017015 regulation of transforming growth factor beta receptor signaling pathway: Signaling Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0017015 describes any process that modulates the frequency, rate or extent of TGF-beta receptor signaling pathway activity.
• TGF-beta receptor signaling is initiated by ligand-induced assembly of type I and type II serine/threonine kinase receptors and is propagated through Smad and non-Smad branches.
• Regulation of this pathway occurs at multiple levels, including ligand availability, receptor trafficking, inhibitory Smads, phosphatases, and feedback loops.
• Dysregulated TGF-beta receptor signaling is implicated in cancer, including glioblastoma, and in motor neuron diseases.
• CRISPR-based knockout, point-mutation, knock-in, and overexpression models enable causal dissection of regulators of this pathway.
• Understanding GO:0017015 supports target discovery in oncology, fibrosis, and neurodegeneration research.
Description
GO:0017015, regulation of transforming growth factor beta receptor signaling pathway, is a biological process term that captures any process modulating the frequency, rate, or extent of activity of a TGF-beta receptor signaling pathway. TGF-beta receptor signaling is a central intercellular communication system that controls proliferation, differentiation, migration, and survival across metazoan tissues. Because the pathway is potent and context-dependent, its activity must be tightly regulated; loss of this control contributes to diseases such as cancer and motor neuron degeneration. Researchers studying GO:0017015 aim to identify the molecular brakes and accelerators that tune receptor signaling, and to determine how these regulators behave in normal and diseased cells. This article integrates the QuickGO definition with verified PubMed literature to summarize the mechanisms, key genes, disease links, and experimental methods relevant to GO:0017015.
regulation of transforming growth factor beta receptor signaling pathway At A Glance
| GO ID | GO:0017015 |
|---|---|
| GO term | regulation of transforming growth factor beta receptor signaling pathway |
| Ontology | biological_process |
| Synonym | regulation of TGF-beta receptor signaling pathway; regulation of TGFbeta receptor signaling pathway; regulation of transforming growth factor beta receptor signalling pathway |
| Major function | Modulates the frequency, rate or extent of TGF-beta receptor signaling pathway activity |
| Pathway context | TGF-beta receptor signaling, including Smad and non-Smad branches |
| Key receptor classes | Type I and type II serine/threonine kinase receptors |
| Disease relevance | Cancer, including glioblastoma, and motor neuron diseases |
What Is GO:0017015?
According to QuickGO, GO:0017015 is defined as any process that modulates the frequency, rate or extent of activity of any TGF-beta receptor signaling pathway. In practice, this includes mechanisms that alter ligand availability, receptor abundance or activity, Smad-mediated signal transduction, and non-Smad branches of the pathway. The term is a biological process and is synonymous with regulation of TGF-beta receptor signaling pathway, regulation of TGFbeta receptor signaling pathway, and regulation of transforming growth factor beta receptor signalling pathway.
Why Is regulation of transforming growth factor beta receptor signaling pathway Important in Cell Biology?
Regulation of TGF-beta receptor signaling is essential because the pathway governs fundamental cell fate decisions, and its dysregulation is a hallmark of multiple human diseases. Understanding GO:0017015 helps researchers identify nodes where the pathway can be therapeutically tuned, and provides a framework for interpreting genetic and pharmacological perturbations in cancer, fibrosis, and neurodegeneration models.
• Controls proliferation, differentiation, migration, and survival decisions in many cell types.
• Provides feedback mechanisms that prevent excessive or prolonged TGF-beta signaling.
• Integrates Smad-dependent and non-Smad signaling branches to shape cellular responses.
• Dysregulation is linked to glioblastoma prognosis and IDH-wildtype tumor biology.
• Implicated in motor neuron diseases, highlighting roles beyond cancer.
• Offers targets for therapeutic modulation of TGF-beta signaling in disease.
• Guides interpretation of receptor expression and signaling data in patient samples.
• Supports development of CRISPR models to test causal roles of candidate regulators.
• Helps distinguish context-dependent effects of TGF-beta across tissues.
• Connects ligand activation mechanisms to downstream transcriptional outputs.
What Happens During regulation of transforming growth factor beta receptor signaling pathway?
Ligand availability and receptor activation
In simple terms: The pathway starts when TGF-beta ligands are available and bind to receptors on the cell surface.
TGF-beta receptor signaling is initiated when ligands engage type I and type II serine/threonine kinase receptors, leading to receptor complex assembly and activation. Regulation at this step includes control of ligand bioavailability and the versatile mechanisms by which ligands activate receptors. Receptor activation is a prerequisite for downstream signaling, so processes that modulate ligand-receptor engagement directly affect pathway output.
Smad-mediated signal transduction
In simple terms: Activated receptors pass the signal to Smad proteins, which carry it into the nucleus.
Activated type I receptors phosphorylate receptor-regulated Smads, which then complex with co-Smad and translocate to the nucleus to regulate transcription. This Smad-dependent branch is a core route by which TGF-beta receptor signaling influences gene expression, and its regulation determines the strength and duration of transcriptional responses.
Non-Smad signaling branches
In simple terms: The receptors can also activate other signaling routes besides Smads.
In addition to Smad signaling, TGF-beta receptors can activate non-Smad pathways that contribute to cellular responses. These non-Smad branches expand the regulatory landscape of GO:0017015, because modulation of these branches can alter the overall output of receptor signaling.
Feedback regulation of the pathway
In simple terms: The pathway can turn itself down through feedback loops.
Feedback regulation is a key mechanism that controls TGF-beta signaling intensity and duration. Such feedback ensures that signaling is self-limiting and responsive to cellular context, and its disruption can lead to excessive or insufficient pathway activity.
Receptor trafficking and turnover
In simple terms: Receptors can be moved or degraded to adjust how much signal is sent.
The abundance and localization of TGF-beta receptors are regulated processes that influence signaling capacity. Although specific trafficking details are beyond the provided citations, the general principle that receptor levels and localization modulate pathway activity is consistent with the biology of TGF-beta signaling.
Key Genes Involved in GO:0017015 regulation of transforming growth factor beta receptor signaling pathway
The following genes and proteins are central to TGF-beta receptor signaling and its regulation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TGFB1 | Ligand that activates TGF-beta receptors | Studying ligand-dependent receptor activation |
| TGFBR1 | Type I receptor kinase that propagates signaling | Core receptor for Smad activation |
| TGFBR2 | Type II receptor kinase that activates type I receptor | Ligand binding and receptor complex assembly |
| SMAD2 | Receptor-regulated Smad mediating transcriptional responses | Smad-dependent signaling branch |
| SMAD3 | Receptor-regulated Smad mediating transcriptional responses | Smad-dependent signaling branch |
| SMAD4 | Co-Smad forming complexes with R-Smads | Nuclear transcriptional regulation |
| SMAD7 | Inhibitory Smad that negatively regulates signaling | Feedback regulation of TGF-beta signaling |
| SMURF1 | E3 ubiquitin ligase regulating receptor turnover | Receptor degradation and feedback |
| SMURF2 | E3 ubiquitin ligase regulating receptor turnover | Receptor degradation and feedback |
| MAPK1 | Non-Smad signaling component | Non-Smad branch of TGF-beta signaling |
| MAPK3 | Non-Smad signaling component | Non-Smad branch of TGF-beta signaling |
| RHOA | Non-Smad signaling component | Non-Smad branch of TGF-beta signaling |
| PIK3CA | Non-Smad signaling component | Non-Smad branch of TGF-beta signaling |
| AKT1 | Non-Smad signaling component | Non-Smad branch of TGF-beta signaling |
| TGFBR3 | Betaglycan, modulates ligand presentation | Ligand activation mechanisms |
| LTBP1 | Ligand sequestration and presentation | Ligand availability regulation |
| BAMBI | Pseudo-receptor that inhibits signaling | Negative regulation of receptor signaling |
How Is regulation of transforming growth factor beta receptor signaling pathway Regulated?
Regulation of TGF-beta receptor signaling is achieved through multiple mechanisms, including feedback loops that adjust pathway activity. Inhibitory Smads such as SMAD7 and E3 ubiquitin ligases such as SMURF1/2 contribute to negative regulation by promoting receptor turnover. Non-Smad branches can also modulate signaling outcomes. Together, these layers ensure that TGF-beta receptor signaling is context-dependent and self-limiting.
regulation of transforming growth factor beta receptor signaling pathway and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| TGFBR1 | Cancer and fibrosis | Knockout or point-mutation cell models |
| TGFBR2 | Glioblastoma and cancer | Knock-in of patient variants |
| SMAD7 | Negative regulation in disease | Overexpression and knockout models |
| SMURF1 | Receptor turnover in disease | Knockout and tagged knock-in |
| TGFB1 | Ligand-driven pathology | Overexpression and knockout models |
Glioblastoma and cancer
TGF-beta receptor expression and signaling have prognostic relevance in glioblastoma, IDH-wildtype, indicating that dysregulation of this pathway is linked to tumor biology and patient outcome. Regulation of TGF-beta receptor signaling is therefore relevant to understanding cancer progression and to identifying potential therapeutic targets.
Motor neuron diseases
TGF-beta signaling has been implicated in motor neuron diseases, suggesting that regulation of this pathway contributes to neuronal survival and degeneration. This expands the disease relevance of GO:0017015 beyond oncology.
General disease mechanisms
Because TGF-beta signaling controls proliferation, differentiation, and survival, its dysregulation can contribute to a range of pathological states. Feedback regulation is particularly important, as loss of negative control can lead to excessive signaling.
From regulation of transforming growth factor beta receptor signaling pathway-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of a candidate regulator alter TGF-beta signaling? | CRISPR knockout cell model |
| Does a specific point mutation change receptor activity? | Point-mutation knock-in |
| How does a disease-associated variant affect pathway output? | Knock-in of the variant |
| Where is the regulator protein localized? | Tagged knock-in |
| Does overexpression mimic disease-associated activation? | Overexpression cell model |
| Which genes modulate the pathway in a genome-wide screen? | CRISPR library screening |
How to Study the regulation of transforming growth factor beta receptor signaling pathway Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Transcriptional changes | Pathway output after perturbation |
| Western blot | Protein phosphorylation and abundance | Smad activation status |
| Co-immunoprecipitation | Protein-protein interactions | Receptor complex assembly |
| Immunofluorescence | Protein localization | Receptor and Smad trafficking |
| Luciferase reporter | Smad-dependent transcription | Pathway activity quantification |
| CRISPR knockout screen | Gene requirement for pathway activity | Regulator discovery |
| Proteomics | Global protein changes | Pathway network analysis |
Transcriptional readouts
Because TGF-beta receptor signaling converges on transcriptional responses via Smads, RNA-seq and reporter assays are commonly used to measure pathway activity and the impact of regulatory perturbations.
Protein interaction and modification assays
Co-immunoprecipitation and western blotting can assess receptor complex formation and Smad phosphorylation, which are core events in TGF-beta signaling. These methods help determine how regulators affect signaling intermediates.
Imaging and localization
Fluorescence imaging of tagged receptors or Smads can reveal changes in localization and complex assembly that underlie pathway regulation. Such approaches complement biochemical assays.
Genetic perturbation screens
CRISPR-based screens enable systematic identification of regulators of TGF-beta receptor signaling, linking genotype to pathway output. These screens can uncover feedback components and non-Smad modulators.
How CRISPR Can Be Used to Study GO:0017015 regulation of transforming growth factor beta receptor signaling pathway
Knockout
CRISPR knockout of candidate regulators can test whether a gene is required for TGF-beta receptor signaling output. For example, knocking out negative regulators such as SMAD7 may enhance pathway activity, while knocking out positive components may reduce it.
Point Mutation
Point mutations can be introduced into receptors or Smads to dissect specific residues required for signaling or regulation. This approach helps distinguish catalytic and interaction functions.
Knock-in
Knock-in of disease-associated variants or tags allows study of their effects on pathway regulation in a native genomic context. Tagged knock-in can also facilitate localization and interaction studies.
Overexpression
Overexpression of ligands, receptors, or regulators can model pathway activation or inhibition states observed in disease. This is useful for testing sufficiency of a candidate regulator.
How EDITGENE Supports regulation of transforming growth factor beta receptor signaling pathway Research
Researchers studying regulation of transforming growth factor beta receptor signaling pathway-related genes often need to determine whether a candidate gene is causally involved in pathway control or disease phenotypes. EDITGENE provides CRISPR-based cell model services to enable such causal experiments.
Contact EDITGENE today to design your custom CRISPR model for regulation of transforming growth factor beta receptor signaling pathway research.
Frequently Asked Questions About regulation of transforming growth factor beta receptor signaling pathway
What is GO:0017015?
GO:0017015 is the Gene Ontology term for regulation of transforming growth factor beta receptor signaling pathway, defined as any process that modulates the frequency, rate or extent of activity of any TGF-beta receptor signaling pathway.
What does regulation of TGF-beta receptor signaling mean?
It refers to cellular mechanisms that adjust the strength, duration, or output of TGF-beta receptor signaling, including feedback and receptor turnover.
What genes are involved in regulation of TGF-beta receptor signaling?
Key genes include TGFBR1, TGFBR2, SMAD2, SMAD3, SMAD4, SMAD7, SMURF1, SMURF2, and non-Smad components such as MAPK1 and AKT1.
How is TGF-beta receptor signaling regulated?
It is regulated by ligand availability, receptor activation and turnover, inhibitory Smads, phosphatases, and feedback loops.
Why is regulation of TGF-beta receptor signaling important in cancer?
Dysregulated TGF-beta receptor signaling is linked to cancer, including prognostic relevance in glioblastoma, IDH-wildtype.
Is TGF-beta receptor signaling involved in motor neuron diseases?
Yes, TGF-beta signaling has been implicated in motor neuron diseases, indicating roles beyond cancer.
What are non-Smad signaling pathways in TGF-beta signaling?
Non-Smad pathways are signaling branches activated by TGF-beta receptors that operate independently of Smad proteins.
How can CRISPR be used to study GO:0017015?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of candidate regulators of TGF-beta receptor signaling.
What methods measure TGF-beta receptor signaling activity?
Common methods include RNA-seq, western blot for Smad phosphorylation, luciferase reporters, and imaging of receptor complexes.
What diseases are associated with dysregulated TGF-beta receptor signaling?
Cancer, including glioblastoma, and motor neuron diseases are associated with dysregulated TGF-beta receptor signaling.
Conclusion
GO:0017015, regulation of transforming growth factor beta receptor signaling pathway, is a critical biological process that controls the intensity and duration of TGF-beta signaling through ligand availability, receptor activation, Smad and non-Smad branches, and feedback mechanisms. Its dysregulation is linked to cancer and motor neuron diseases, making it a key area for therapeutic and mechanistic research. CRISPR-based cell models and screening approaches provide powerful tools to dissect these regulatory mechanisms and identify new targets.
References
- 1. Togni C et al.. 2022. Prognostic Relevance of Transforming Growth Factor-β Receptor Expression and Signaling in Glioblastoma, Isocitrate Dehydrogenase-Wildtype.. J Neuropathol Exp Neurol 81(3):225-235 PMID: 35190826
- 2. Yan X et al.. 2018. Feedback regulation of TGF-β signaling.. Acta Biochim Biophys Sin (Shanghai) 50(1):37-50 PMID: 29228156
- 3. Chia ZJ et al.. 2024. Transforming growth factor-β receptors: versatile mechanisms of ligand activation.. Acta Pharmacol Sin 45(7):1337-1348 PMID: 38351317
- 4. Wrana JL. 2000. Crossing Smads.. Sci STKE 2000(23):re1 PMID: 11752591
- 5. Massagué J et al.. 1992. TGF-beta receptors.. Mol Reprod Dev 32(2):99-104 PMID: 1322148
- 6. Ikushima H et al.. 2011. Biology of transforming growth factor-β signaling.. Curr Pharm Biotechnol 12(12):2099-107 PMID: 21619537
- 7. Mu Y et al.. 2012. Non-Smad signaling pathways.. Cell Tissue Res 347(1):11-20 PMID: 21701805
- 8. Katsuno M et al.. 2011. Transforming growth factor-β signaling in motor neuron diseases.. Curr Mol Med 11(1):48-56 PMID: 21189118
